These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25488166)

  • 1. Insufficient control of heart rate in stable coronary artery disease patients in Latvia.
    Balode I; Mintāle I; Latkovskis G; Jēgere S; Narbute I; Bajāre I; Greenlaw N; Steg PG; Ferrari R; Ērglis A;
    Medicina (Kaunas); 2014; 50(5):295-302. PubMed ID: 25488166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
    Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
    Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease].
    Sun Y; Yu J; Hu D;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jan; 44(1):19-26. PubMed ID: 26813548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry.
    Stępińska J; Marona M; Greenlaw N; Steg G;
    Kardiol Pol; 2014; 72(11):1156-64. PubMed ID: 25001472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
    Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy.
    Jiang J; Cong H; Zhang Y; Li Z; Tao G; Li X; Qing L; Tan N; Zhao Z; Dong Y; Ji Z; Chen Y; Ge J; He B; Sun Y; Cao K; Huo Y
    Int J Med Sci; 2017; 14(5):477-483. PubMed ID: 28539824
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
    Steg PG; Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox KM;
    PLoS One; 2012; 7(5):e36284. PubMed ID: 22570699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate and B-blockade in stable coronary artery disease in Greece.
    Sbarouni E; Voudris V; Georgiadou P; Hamilos M; Steg G; Fox KM; Greenlaw N; Vardas PE;
    Hellenic J Cardiol; 2015; 56(2):112-7. PubMed ID: 25854439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate and use of β-blockers in Mexican stable outpatients with coronary artery disease.
    Alcocer-Gamba MA; Martínez-Sánchez C; Verdejo-Paris J; Ferrari R; Fox K; Greenlaw N; Steg Philippe G;
    Arch Cardiol Mex; 2015; 85(4):270-7. PubMed ID: 25921309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study.
    Andrikopoulos G; Pastromas S; Kartalis A; Toli K; Mantas I; Tzeis S; Kyrpizidis C; Olympios C; Manolis AJ; Foussas S; Kranidis A; Pras A; Pipilis A; Chryssos D; Gotsis A; Trikas A; Richter D; Alexopoulos D; Parthenakis F; Theodorakis G; Konstantinides S; Vardas P
    Hellenic J Cardiol; 2012 Mar; 53(2):118-26. PubMed ID: 22484777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and control of cardiovascular risk factors in stable coronary artery outpatients in India compared with the rest of the world: An analysis from international CLARIFY registry.
    KauL U; Natrajan S; Dalal J; Saran RK
    Indian Heart J; 2017; 69(4):447-452. PubMed ID: 28822509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry.
    Erglis A; Mintale I; Latkovskis G; Balode I; Jegere S; Bajare I; Rozenbergs A; Greenlaw N; Ferrari R; Steg PG;
    Medicina (Kaunas); 2015; 51(4):240-6. PubMed ID: 26424189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an ambulatory population with stable coronary artery disease and importance of heart rate: the PULSAR registry.
    Seabra-Gomes R;
    Rev Port Cardiol; 2010 Apr; 29(4):483-508. PubMed ID: 20734572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inadequate control of heart rate in patients with stable angina: results from the European heart survey.
    Daly CA; Clemens F; Sendon JL; Tavazzi L; Boersma E; Danchin N; Delahaye F; Gitt A; Julian D; Mulcahy D; Ruzyllo W; Thygesen K; Verheugt F; Fox KM;
    Postgrad Med J; 2010 Apr; 86(1014):212-7. PubMed ID: 20354044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of left ventricular ejection fraction and heart rate values in a cohort of stable coronary patients: the INDYCE registry.
    Tabet JY; Malergue MC; Guenoun M; Paganelli F; Meurin P; Not D; Jourdain P; Guedj-Meynier D;
    Arch Cardiovasc Dis; 2010; 103(6-7):354-62. PubMed ID: 20800799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine in stable coronary artery disease without clinical heart failure.
    Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R;
    N Engl J Med; 2014 Sep; 371(12):1091-9. PubMed ID: 25176136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.
    Badar AA; Perez-Moreno AC; Hawkins NM; Jhund PS; Brunton AP; Anand IS; McKelvie RS; Komajda M; Zile MR; Carson PE; Gardner RS; Petrie MC; McMurray JJ
    Circ Heart Fail; 2015 Jul; 8(4):717-24. PubMed ID: 26067854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
    Ignjatovic V; Pavlovic S; Miloradovic V; Andjelkovic N; Davidovic G; Djurdjevic P; Stolic R; Iric-Cupic V; Simic I; Ignjatovic VD; Petrovic N; Smiljanic Z; Zdravkovic V; Simovic S; Jovanovic D; Nesic J
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):44-52. PubMed ID: 25868659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.